✦ LIBER ✦

Pharmacogenetic screening to prevent carbamazepine-induced toxic epidermal necrolysis and Stevens–Johnson syndrome: a critical appraisal

✍ Scribed by K. Wu; N.J. Reynolds

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Response 1 to pharmacogenetic screening

✍ C.Y. Shen; Y.T. Chen 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 44 KB

Response 2 to pharmacogenetic screening

✍ A. Alfirevic; M. McCormack; M. Pirmohamed; G.L. Cavalleri 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 51 KB

Commentary: pharmacogenetic screening to

✍ A.V. Anstey 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 36 KB

HLA-B*1511 is a risk factor for carbamaz

✍ Nahoko Kaniwa; Yoshiro Saito; Michiko Aihara; Kayoko Matsunaga; Masahiro Tohkin; 📂 Article 📅 2010 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 70 KB

Soluble Fas Ligand: Is It a Critical Med

✍ Murata, Junko; Abe, Riichiro 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 62 KB

Strong association between HLA-B*1502 an

✍ Yan Zhang; Jin Wang; Li-Mei Zhao; Wei Peng; Guo-Qing Shen; Ling Xue; Xiao-Xian Z 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 87 KB